Myriad Genetics reported $800K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Accelerate Diagnostics AXDX:US 80K 11K
Agilent A:US $ 3M 0M
Becton, Dickinson and BDX:US $ 365M 0M
Bio Rad Laboratories BIO:US $ 0M 0M
Biocept BIOC:US $ 0M 0M
Danaher DHR:US $ 9M 0M
Exact Sciences EXAS:US $ 1.77M 0.01M
Hologic HOLX:US $ 3M 0M
Illumina ILMN:US $ 2M 0M
Mettler Toledo International MTD:US 448K 0
Myriad Genetics MYGN:US $ 0.8M 0M
Nanostring Technologies NSTG:US $ 0M 0M
Orasure Technologies OSUR:US $ 0M 0M
Quest Diagnostics DGX:US $ 2M 0M
Repligen RGEN:US $ 0.56M 0M
Veracyte VCYT:US $ 0.07M 0M